Ascentage Pharma Group International
HKEX:6855.HK
44.2 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -932.862 | -882.924 | -782.424 | -677.606 | -1,480.714 | -346.909 | -120.116 | -107.839 |
| Depreciation & Amortization
| 93.195 | 60.916 | 27.526 | 26.489 | 25.793 | 18.462 | 12.501 | 1.547 |
| Deferred Income Tax
| -4.824 | -16.199 | 10.927 | -26.295 | -81.965 | -11.395 | 0 | -10 |
| Stock Based Compensation
| 31.503 | 22.105 | 46.971 | 74.027 | 70.822 | 27.575 | 0 | 64.993 |
| Change In Working Capital
| -9.146 | -5.906 | -57.898 | -47.732 | 11.143 | 27.078 | 10.531 | 2.147 |
| Accounts Receivables
| -91.537 | -0.388 | -53.968 | 0 | 0 | 0 | 0.556 | -0.301 |
| Inventory
| -6.719 | -5.518 | -3.93 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 91.537 | -110.279 | 17.013 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -2.427 | 110.279 | -17.013 | -47.732 | 11.143 | 14.748 | 9.975 | 2.448 |
| Other Non Cash Items
| 96.057 | 168.093 | 150.219 | 41.161 | 994.616 | 47.522 | -10.901 | 3.259 |
| Operating Cash Flow
| -726.077 | -653.915 | -604.679 | -609.956 | -460.305 | -237.667 | -107.985 | -45.893 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -56.844 | -203.288 | -435.415 | -249.921 | -77.456 | -49.46 | -20.536 | -3.371 |
| Acquisitions Net
| -20 | -20 | -36.2 | -144.109 | -19.607 | -33.378 | 0 | 6.097 |
| Purchases Of Investments
| 0 | -130 | -1,783.816 | -2,170.111 | -1,806.601 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 150 | 1,789.788 | 2,314.22 | 1,826.208 | 0 | 0 | 0 |
| Other Investing Activites
| 98.766 | -181.324 | -0.879 | 142.554 | -123.877 | 375.646 | -209.811 | -155.337 |
| Investing Cash Flow
| 21.922 | -384.612 | -466.522 | -107.367 | -201.333 | 292.808 | -230.347 | -152.611 |
| Financing Activities: | ||||||||
| Debt Repayment
| -2.591 | 709.113 | 548.587 | 432.805 | 50 | 35 | 0 | 0 |
| Common Stock Issued
| 470.089 | 0.019 | 1,300.645 | 634.217 | 432.279 | 0.015 | 0 | 0 |
| Common Stock Repurchased
| -5.923 | -26.776 | -25.874 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -92.824 | -63.088 | -41.971 | -27.019 | -39.917 | 825.148 | 58.362 | 435.535 |
| Financing Cash Flow
| 368.751 | 619.268 | 1,781.387 | 1,040.003 | 442.362 | 860.163 | 58.362 | 435.535 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 27.813 | 58.012 | -23.279 | -41.687 | 1.174 | 26.963 | 0.262 | -0.104 |
| Net Change In Cash
| -307.591 | -361.247 | 686.907 | 280.993 | -218.102 | 942.267 | -279.708 | 236.927 |
| Cash At End Of Period
| 1,038.048 | 1,345.639 | 1,706.886 | 1,019.979 | 738.986 | 957.088 | 14.821 | 294.529 |